Review Article

Association between Perioperative Blood Transfusions and Clinical Outcomes in Patients Undergoing Bladder Cancer Surgery: A Systematic Review and Meta-Analysis Study

Table 1

(a) Information on individual study for overall survival. (b) Information on individual study for cancer-specific survival. (c) Information on individual study for recurrence-free survival.
(a)

AuthorYear Ottawa-Newcastle score = total = transfused patients = nontransfused patientsHazard ratio 95% CI for HR

Kluth et al. [9]20148.002895112817671.10.99–1.22
Linder et al. [20]20139.00206012797811.271.12–1.45
Moschini et al. [17]20157.0013734639101.451.02–2.08
Morgan et al. [21]20137.007773234541.171.01–1.36
Abel et al. [10]20147.002811621191.491.00–2.25
Abel et al. [10]20147.0014858156701.41.2–1.62
Soubra et al. [18]20158.005462113943231.1091.011–1.21
Sadeghi et al. [22]20127.006382094291.150.91–1.45
Gierth et al. [23]20157.006844232611.8221.45–2.29

(b)

AuthorYearOttawa-Newcastle score = total = transfused patients = nontransfused patientsHazard ratio 95% CI for HR

Kluth et al. [9]20148.002895112817671.10.96–1.27
Linder et al. [20]20139.00206012797811.311.1–1.57
Moschini et al. [17]20157.0013734639101.61.2–2.26
Abel et al. [10]20147.002811621191.771.06–2.94
Abel et al. [10]20147.0014858156701.551.24–1.94
Soubra et al. [18]20158.005462113943231.0520.919–1.204
Sadeghi et al. [22]20127.006382094291.20.85–1.69
Gierth et al. [23]20157.006844232611.351.015–1.795

(c)

AuthorYearOttawa-Newcastle score = total = transfused patients = nontransfused patientsHazard ratio 95% CI for HR

Kluth et al. [9]20148.002895112817671.130.99–1.28
Linder et al. [20]20139.00206012797811.201.01–1.42
Moschini et al. [17]20157.0013734639101.241.03–1.65
Abel et al. [10]20147.002811621191.450.84–2.51
Abel et al. [10]20147.0014858156701.451.16–1.81
Gierth et al. [23]20157.006844232611.160.886–1.519

CI: confidence interval. HR: hazard ratio.